Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Find trials by sponsor or company

Search by sponsors

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “AstraZeneca”

AZD1656 in Transplantation With Diabetes tO PromoTe Immune TOleraNceCompleted
NCT05216172Phase 2Updated Jun 20, 2024
Sponsor: Queen Mary University of London
Type 2 Diabetes · Diabetes Mellitus, Type 2 · Renal Transplant · Kidney Transplant; Complications
United Kingdom
A Study to Determine Safety of Durvalumab After Sequential Chemo Radiation in Patients With Unresectable Stage III Non-Small Cell Lung CancerCompleted
NCT03693300Phase 2Updated Jun 18, 2024
Sponsor: AstraZeneca
Non-small Cell Lung Cancer (NSCLC)
United States, France, Germany, Italy, Spain +1 more
Drug-drug Interaction Study With AZD5305 and Itraconazole in Patients With Advanced Solid MalignanciesCompleted
NCT05573724Phase 1Updated Jun 18, 2024
Sponsor: AstraZeneca
Advanced Solid Malignancies
Moldova, Romania
Effects of Dapagliflozin in Non-diabetic Patients With ProteinuriaCompleted
NCT03190694Phase 2Updated Jun 17, 2024
Sponsor: Hiddo Lambers Heerspink
Chronic Kidney Diseases · Proteinuria
Canada, Malaysia, Netherlands
A Phase II, Study to Determine the Preliminary Efficacy of Novel Combinations of Treatment in Patients With Platinum Refractory Extensive-Stage Small-Cell Lung CancerCompleted
NCT02937818Phase 2Updated Jun 7, 2024
Sponsor: AstraZeneca
Platinum Refractory Extensive-Stage Small Cell Lung Carcinoma
Germany, Hungary, Poland, Spain, Ukraine
Study of AZD2014 and Palbociclib in Patients With Estrogen Receptor Positive (ER+) Metastatic Breast CancerCompleted
NCT02599714Phase 1Updated Jun 6, 2024
Sponsor: AstraZeneca
Advanced and Metastatic Breast Cancer
United States, United Kingdom
A Prospective, Randomized, Open-Label, Cross-Over Study of Lokelma to Control Interdialytic HyperkalemiaCompleted
NCT05535920Phase 4Updated Jun 5, 2024
Sponsor: NephroNet, Inc.
Hyperkalemia
United States
Lurbinectedin Combined With Durvalumab in Pre-treated Patients With Extensive Stage Small-cell Lung CancerWithdrawn
NCT05572476Phase 2Updated Jun 5, 2024
Sponsor: Institut Bergonié
Small Cell Lung Cancer · Platinum-Sensitive Lung Small Cell Carcinoma · Extensive-stage Small-cell Lung Cancer
France
Association of the Risk for Thrombotic Thrombocytopenia Syndrome and Exposure To COVID-19 VaccinesCompleted
NCT05252442N/AUpdated May 30, 2024
Sponsor: AstraZeneca
Covid-19
United Kingdom
An ADME Study of [14C]AZD4604 and the Absolute Bioavailability of AZD4604Completed
NCT06157255Phase 1Updated May 29, 2024
Sponsor: AstraZeneca
Asthma
United Kingdom
Study on Determine the Utilisation and Clinical Outcomes of Evusheld in COVID-19 PrEP in ChinaCompleted
NCT05917951N/AUpdated May 29, 2024
Sponsor: AstraZeneca
COVID-19
China
Responses to CPET in Subjects With Persistent Exercise Intolerance After COVID-19: an Open-Source Exercise NetworkCompleted
NCT05532995N/AUpdated May 21, 2024
Sponsor: Association pour la Complementarite des Connaissances et des Pratiques de la Pneumologie
COVID-19
Canada, France, Martinique, Switzerland
Compare the Impact of Xuezhikang and Atorvastatin on Glucose Metabolism in Dyslipidemia Patients With PrediabetesCompleted
NCT05238012Phase 4Updated May 21, 2024
Sponsor: Heart Health Research Center
Metabolism Disorder, Lipid · Metabolism Disorder, Glucose
China
Retrospective Analysis to Describe Patient Profiles, Current Treatment Patterns and Economic Burden for Asthma Patients in UAE. A Descriptive Analysis of the Asthma Patient Population in the Emirate of Dubai With Respect to Healthcare Resource Utilization, Costs, and Asthma-related Treatment PatternCompleted
NCT03963141N/AUpdated May 21, 2024
Sponsor: AstraZeneca
Asthma
United Arab Emirates
Prevalence and Clinicopathologic Features of Different HER2 Level in Chinese Breast Cancer PatientsCompleted
NCT05203458N/AUpdated May 16, 2024
Sponsor: AstraZeneca
Breast Cancer, HER2
China
Assess the Safety, Tolerability and Pharmacokinetics of AZD5055 Following Single and Multiple Ascending Doses in Healthy ParticipantsCompleted
NCT05134727Phase 1Updated May 16, 2024
Sponsor: AstraZeneca
Idiopathic Pulmonary Fibrosis
United States
Asthma Control in a Dutch Primary Care PopulationCompleted
NCT04456270N/AUpdated May 14, 2024
Sponsor: General Practitioners Research Institute
Asthma · Asthma; Eosinophilic · Asthma Chronic · Asthma; Status
Netherlands
Evaluate the Safety of Linaclotide in IBS-C Patients in ChinaCompleted
NCT04462900N/AUpdated May 13, 2024
Sponsor: AstraZeneca
Irritable Bowel Syndrome-IBS
China
Dapagliflozin in Non-diabetic Stage IV CKDCompleted
NCT04794517Phase 2Updated May 10, 2024
Sponsor: Mario Negri Institute for Pharmacological Research
Chronic Kidney Diseases
Italy
Real-World Treatment Patterns and Patient Reported Outcome in COPD (REMIND)Completed
NCT05903989N/AUpdated May 10, 2024
Sponsor: AstraZeneca
COPD
Japan
A Single Arm Study of Acalabrutinib Conbimed With Obinutuzumab in Chinese Patients With Previously Untreated CLLRecruiting
NCT05950997NAUpdated May 9, 2024
Sponsor: The First Affiliated Hospital with Nanjing Medical University
Chronic Lymphocytic Leukemia
China
RICE: Radio-Immuno-Chemotherapy of Cancer of the EsophagusUnknown
NCT04159974Phase 2Updated May 9, 2024
Sponsor: University of Cologne
Esophageal Adenocarcinoma
Germany
Study of Olaparib/Trabectedin vs. Doctor's Choice in Solid TumorsCompleted
NCT03127215Phase 2Updated May 8, 2024
Sponsor: National Center for Tumor Diseases, Heidelberg
Cancers With DNA Repair-Deficiency
Germany
Saracatinib Trial TO Prevent FOPUnknown
NCT04307953Phase 2Updated May 3, 2024
Sponsor: Amsterdam UMC, location VUmc
Fibrodysplasia Ossificans Progressiva
Germany, Netherlands, United Kingdom
Predictive Signature of Benralizumab ResponseRecruiting
NCT04565483Phase 4Updated Apr 26, 2024
Sponsor: Nantes University Hospital
Asthma; Eosinophilic · Severe Asthma
France

Previous page Next page